0 NASDAQ Companies - December 26, 2023Yoshitsu Co., Ltd Receives Nasdaq Notification Letter Regarding Minimum Bid Price DeficiencyTokyo, Japan, Dec. 26, 2023 (GLOBE NEWSWIRE) — Yoshitsu Co., Ltd (“Yoshitsu” or the “Company”) (Nasdaq: TKLF), a retailer and […]Read More
0 NASDAQ Companies - December 26, 2023Swvl Reports Receipt of Nasdaq Minimum Bid Price NotificationDUBAI, United Arab Emirates, Dec. 26, 2023 (GLOBE NEWSWIRE) — Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a […]Read More
0 NASDAQ Companies - December 26, 2023Coherus Announces FDA Approval of UDENYCA ONBODY™, a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv– Innovative design enables five-minute pegfilgrastim delivery time – – Unique, automatic, retractable needle mechanism engineered to maximize safety and […]Read More
0 NASDAQ Companies - December 26, 2023Cytokinetics to Host Investor Call on December 27 to Discuss the Topline Results from SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Obstructive Hypertrophic CardiomyopathySOUTH SAN FRANCISCO, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of its […]Read More
0 NASDAQ Companies - December 26, 2023Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per ShareVANCOUVER, Wash., Dec. 26, 2023 (GLOBE NEWSWIRE) — Riverview Bancorp, Inc. (Nasdaq GSM: RVSB) (“Riverview” or the “Company”) today announced […]Read More
0 NASDAQ Companies - December 26, 2023Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingDALLAS, Dec. 26, 2023 (GLOBE NEWSWIRE) — On December 26, 2023, Hallmark Financial Services, Inc. provided notice to the Nasdaq […]Read More
0 NASDAQ Companies - December 26, 2023Scilex Holding Company Announces Filing of a New Drug Submission (NDS) to Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in CanadaELYXYB® is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or […]Read More
0 NASDAQ Companies - December 26, 2023Red Cat Endorses Passing of the American Security Drone ActSAN JUAN, Puerto Rico, Dec. 26, 2023 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), […]Read More
0 NASDAQ Companies - December 26, 2023VERB’s MARKET.live Adds Twenty More Retailers to Its Livestream Social Shopping PlatformLOS ALAMITOS, Calif. and LAS VEGAS, Dec. 26, 2023 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or […]Read More
0 NASDAQ Companies - December 26, 2023Sunrise New Energy Announces Breakthrough Achievement in Sodium-ion Battery Hard Carbon Composite Material with Approval of Invention Patent by National Intellectual Property OfficeZIBO, China, Dec. 26, 2023 (GLOBE NEWSWIRE) — Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: […]Read More